Effect of the angiotensin I converting enzyme inhibitor, MK-421, on experimentally induced drinking. - Suppr | 超能文献

Effect of the angiotensin I converting enzyme inhibitor, MK-421, on experimentally induced drinking.

作者信息

Fregly M J, Fater D C, Greenleaf J E

出版信息

Appetite. 1982 Dec;3(4):309-19. doi: 10.1016/s0195-6663(82)80048-2.

DOI:10.1016/s0195-6663(82)80048-2

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Effect of the angiotensin I converting enzyme inhibitor, MK-421, on experimentally induced drinking.

Appetite. 1982 Dec;3(4):309-19. doi: 10.1016/s0195-6663(82)80048-2.

2

Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.口服活性血管紧张素I转换酶抑制剂依那普利（MK-421）对清醒大鼠血压、活性和非活性血浆肾素、尿前列腺素E2及激肽释放酶排泄的影响。

Can J Physiol Pharmacol. 1984 Jan;62(1):116-23. doi: 10.1139/y84-019.

3

A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.

Clin Exp Pharmacol Physiol. 1983 Mar-Apr;10(2):131-45. doi: 10.1111/j.1440-1681.1983.tb00179.x.

4

Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.在自发性高血压大鼠和肾性高血压大鼠中，单剂量MK-421和卡托普利的血管紧张素I阻断作用与降压特性之间的关系。

Eur J Pharmacol. 1981 Dec 3;76(2-3):167-76. doi: 10.1016/0014-2999(81)90498-2.

5

Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).转化酶抑制剂马来酸依那普利（MK - 421）的药理特性。

Fed Proc. 1983 Feb;42(2):167-70.

6

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.N-[(S)-1-羧基-3-苯基丙基]-L-丙氨酰-L-脯氨酸及其乙酯（MK-421）对体外血管紧张素转换酶及体内血管紧张素I升压反应的影响。

J Pharmacol Exp Ther. 1981 Mar;216(3):552-7.

7

Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.两种血管紧张素转换酶抑制剂，依那普利和卡托普利，会增加大鼠的盐食欲。

J Toxicol Environ Health. 1984;14(5-6):715-22. doi: 10.1080/15287398409530620.

8

Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.强效血管紧张素转换酶抑制剂N-[1(S)-(乙氧羰基)-3-苯基丙基]-(S)-丙氨酰-(S)-焦谷氨酸的合成与药理学

J Med Chem. 1985 Nov;28(11):1596-602. doi: 10.1021/jm00149a009.

9

Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.血管紧张素转换酶抑制剂MK421（依那普利）具有血管减压作用的证据，该作用独立于对血管紧张素II形成的阻断。

J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1036-42.

10

Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.用MK 421进行抗高血压治疗：血管紧张素II - 肾素关系以评估转换酶阻断的疗效。

J Cardiovasc Pharmacol. 1982 Nov-Dec;4(6):966-72.

引用本文的文献

1

Pharmacological investigations of the mechanisms underlying the effects of peripheral 5-HT on flavour consumption and preference.外周5-羟色胺对风味物质摄入及偏好影响机制的药理学研究

Psychopharmacology (Berl). 1986;89(2):192-7. doi: 10.1007/BF00310628.

2

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.依那普利。对其药效学和药代动力学特性以及在高血压和充血性心力衰竭中的治疗用途的综述。

Drugs. 1986 Mar;31(3):198-248. doi: 10.2165/00003495-198631030-00002.

3

Systemic and coronary haemodynamics and pharmacodynamics of enalapril and enalaprilat in congestive heart failure.依那普利和依那普利拉在充血性心力衰竭中的全身及冠状动脉血流动力学与药效学

Drugs. 1990;39 Suppl 4:29-40; discussion 41-2. doi: 10.2165/00003495-199000394-00007.